Skip to main content

Peer Review reports

From: Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study

Original Submission
4 Apr 2023 Submitted Original manuscript
24 Apr 2023 Reviewed Reviewer Report
2 Jun 2023 Reviewed Reviewer Report
23 Jun 2023 Author responded Author comments - Aubrey Manack Adams
Resubmission - Version 2
23 Jun 2023 Submitted Manuscript version 2
26 Jun 2023 Editorially accepted
3 Aug 2023 Article published 10.1186/s10194-023-01622-0

You can find further information about peer review here.

Back to article page